Beyond Genetic Enhancement: The Enhanced Steatosis Index Demands Risk‐Stratified Thresholds and Subgroup‐Specific Solutions

Key Points

• The enhanced steatosis index necessitates new classification for risk stratification based on individual factors.
• Recent findings emphasize subgroup-specific solutions to address variations in steatosis index outcomes across different populations.
• Assessment using the enhanced steatosis index can lead to more personalized medical approaches, improving patient care.
• The call for targeted solutions may enable better management of steatosis-related conditions in clinical settings.

Abstract